iTeos Therapeutics, Inc. (ITOS) Tops Q3 EPS by 12c

iTeos Therapeutics, Inc. (NASDAQ: ITOS) reported Q3 EPS of ($1.05), $0.12 better than the analyst estimate of ($1.17).

For earnings history and earnings-related data on iTeos Therapeutics, Inc. (ITOS) click here.

You May Also Be Interested In

• Raymond James Starts SpaceX (SPCX) at Strong Buy, PT Street High $800
• MarketAxess reports June and Q2 2026 trading volume data
• Mizuho Reiterates Outperform Rating on Walmart (WMT)